|

[18F]FluorThanatrace ([18F]FTT) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Early 1: 1

Top Sponsors

  • Heather Wachtel1

Indications

  • Paraganglioma1
  • Pheochromocytoma1
  • Cancer1

Philadelphia, Pennsylvania1 trial

In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

Abramson Cancer Center of the University of Pennsylvania

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.